Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swaroop Kumar Pandey

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effectsManikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 7, 2024
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppressionManikandan Santhanam, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy. Oncology|February 2, 2026
Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effectsManikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 10, 2021
Therapeutic strategies to overcome taxane resistance in cancerTuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Environmental Science. Processes & Impacts|June 24, 2020
Toxicity of exhaust particulates and gaseous emissions from gasohol (ethanol blended gasoline)-fuelled spark ignition enginesAvinash Kumar Agarwal, Akhilendra Pratap Singh, Tarun Gupta, et al.
European Journal of Medicinal Chemistry|August 9, 2012
One pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agentsSeerat Fatima, Anindra Sharma, Reshu Saxena, et al.
Current Pharmaceutical Design|October 31, 2025
VLP-based Cancer Therapy: Past, Present, and Future ProspectsAmisha S Raikar, Swaroop Kumar Pandey, Ayush Kulshreshtha, et al.
Parasitology|May 28, 2016
Pyrrolidine-Acridine hybrid in Artemisinin-based combination: a pharmacodynamic studySwaroop Kumar Pandey, Subhasish Biswas, Sarika Gunjan, et al.
Translational Neurodegeneration|January 10, 2023
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathologyAnkit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration|December 28, 2022
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathologyAnkit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effectsManikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 7, 2024
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppressionManikandan Santhanam, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy. Oncology|February 2, 2026
Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effectsManikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 10, 2021
Therapeutic strategies to overcome taxane resistance in cancerTuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Environmental Science. Processes & Impacts|June 24, 2020
Toxicity of exhaust particulates and gaseous emissions from gasohol (ethanol blended gasoline)-fuelled spark ignition enginesAvinash Kumar Agarwal, Akhilendra Pratap Singh, Tarun Gupta, et al.
European Journal of Medicinal Chemistry|August 9, 2012
One pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agentsSeerat Fatima, Anindra Sharma, Reshu Saxena, et al.
Current Pharmaceutical Design|October 31, 2025
VLP-based Cancer Therapy: Past, Present, and Future ProspectsAmisha S Raikar, Swaroop Kumar Pandey, Ayush Kulshreshtha, et al.
Parasitology|May 28, 2016
Pyrrolidine-Acridine hybrid in Artemisinin-based combination: a pharmacodynamic studySwaroop Kumar Pandey, Subhasish Biswas, Sarika Gunjan, et al.
Translational Neurodegeneration|January 10, 2023
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathologyAnkit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, et al.
Translational Neurodegeneration|December 28, 2022
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathologyAnkit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, et al.
Pageof 4